Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Guardant Health Profit Margin 2017-2020 | GH

Current and historical gross margin, operating margin and net profit margin for Guardant Health (GH) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Guardant Health net profit margin as of March 31, 2020 is -30.27%.
  
Guardant Health Annual Profit Margins
Guardant Health Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $8.136B $0.214B
Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. It launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant Health Inc. is based in REDWOOD CITY, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $144.877B 15.73
Bristol Myers Squibb (BMY) United States $133.725B 11.17
CSL (CSLLY) Australia $90.574B 0.00
Gilead Sciences (GILD) United States $89.976B 12.95
Vertex Pharmaceuticals (VRTX) United States $72.806B 40.63
Regeneron Pharmaceuticals (REGN) United States $70.981B 27.36
Illumina (ILMN) United States $58.485B 60.10
Biogen (BIIB) United States $44.036B 7.54
Seattle Genetics (SGEN) United States $29.412B 0.00
Moderna (MRNA) United States $28.948B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $24.547B 0.00
Genmab (GMAB) Denmark $23.368B 19.23
Alexion Pharmaceuticals (ALXN) United States $22.980B 9.58
Genmab (GNMSF) Denmark $22.277B 66.14
Incyte (INCY) United States $22.126B 0.00
BioMarin Pharmaceutical (BMRN) United States $22.069B 200.07
BeiGene (BGNE) Cayman Islands $19.808B 0.00
BioNTech SE (BNTX) Germany $19.339B 0.00
Alnylam Pharmaceuticals (ALNY) United States $17.569B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.496B 70.16
Exact Sciences (EXAS) United States $14.278B 0.00
Galapagos (GLPG) Belgium $12.647B 37.20
Sarepta Therapeutics (SRPT) United States $12.340B 0.00
Horizon Therapeutics Public (HZNP) Ireland $12.032B 29.61
ARGENX SE-ADR (ARGX) Netherlands $11.190B 0.00
QIAGEN (QGEN) Netherlands $11.144B 32.40
Bio-Techne Corp (TECH) United States $10.659B 70.42
Immunomedics (IMMU) United States $10.254B 0.00
Novavax (NVAX) United States $9.034B 0.00
Repligen (RGEN) United States $8.310B 131.89
Ascendis Pharma (ASND) Denmark $7.614B 0.00
Exelixis (EXEL) United States $7.265B 25.47
ACADIA Pharmaceuticals (ACAD) United States $6.744B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $6.600B 16.42
CRISPR Therapeutics AG (CRSP) Switzerland $6.491B 201.09
Emergent Biosolutions (EBS) United States $6.245B 24.74
Vir Biotechnology (VIR) United States $5.839B 0.00
Acceleron Pharma (XLRN) United States $5.668B 0.00
Mirati Therapeutics (MRTX) United States $5.546B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.062B 0.00
Adaptive Biotechnologies (ADPT) United States $5.056B 0.00
Reata Pharmaceuticals (RETA) United States $4.962B 0.00
Zai Lab (ZLAB) China $4.663B 0.00
MorphoSys AG (MOR) Germany $4.534B 35.16
MyoKardia (MYOK) United States $4.498B 0.00
Global Blood Therapeutics (GBT) United States $4.295B 0.00
NeoGenomics (NEO) United States $4.263B 1286.67
China Biologic Products (CBPO) China $4.196B 23.33
Blueprint Medicines (BPMC) United States $4.154B 0.00
Halozyme Therapeutics (HALO) United States $3.850B 0.00
Amicus Therapeutics (FOLD) United States $3.847B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.808B 0.00
Bluebird Bio (BLUE) United States $3.494B 0.00
Inovio Pharmaceuticals (INO) United States $3.271B 0.00
Arena Pharmaceuticals (ARNA) United States $3.189B 0.00
Alkermes (ALKS) Ireland $2.971B 62.27
Principia Biopharma (PRNB) United States $2.925B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.763B 0.00
Insmed (INSM) United States $2.743B 0.00
Amarin (AMRN) Ireland $2.610B 0.00
Fate Therapeutics (FATE) United States $2.580B 0.00
Denali Therapeutics (DNLI) United States $2.563B 0.00
Twist Bioscience (TWST) United States $2.417B 0.00
Sorrento Therapeutics (SRNE) United States $2.049B 0.00
PHARMA MAR SA (PHMMF) Spain $1.922B 0.00
Ligand Pharmaceuticals (LGND) United States $1.911B 64.72
UniQure (QURE) Netherlands $1.893B 0.00
Viela Bio (VIE) United States $1.879B 0.00
Editas Medicine (EDIT) United States $1.744B 0.00
I-Mab (IMAB) China $1.735B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.693B 0.00
Mesoblast (MESO) Australia $1.678B 0.00
Sangamo Therapeutics (SGMO) United States $1.626B 0.00
Eidos Therapeutics (EIDX) United States $1.579B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.556B 0.00
Zymeworks (ZYME) Canada $1.478B 0.00
Epizyme (EPZM) United States $1.452B 0.00
Adverum Biotechnologies (ADVM) United States $1.436B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.410B 0.00
Zealand Pharma (ZEAL) Denmark $1.405B 0.00
Revance Therapeutics (RVNC) United States $1.398B 0.00
Intra-Cellular Therapies (ITCI) United States $1.389B 0.00
Mersana Therapeutics (MRSN) United States $1.383B 0.00
Cytokineticsorporated (CYTK) United States $1.348B 0.00
Coherus BioSciences (CHRS) United States $1.293B 9.02
NGM Biopharmaceuticals (NGM) United States $1.287B 0.00
REGENXBIO (RGNX) United States $1.278B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
Arvinas (ARVN) United States $1.264B 0.00
Alector (ALEC) United States $1.223B 0.00
NantKwest (NK) United States $1.186B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.177B 0.00
Alcobra (ARCT) United States $1.113B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.109B 0.00
Akcea Therapeutics (AKCA) United States $1.104B 0.00
Compugen (CGEN) Israel $1.082B 0.00
Retrophin (RTRX) United States $1.026B 0.00
VBI Vaccines (VBIV) United States $0.999B 0.00
Intellia Therapeutics (NTLA) United States $0.989B 0.00
Beam Therapeutics (BEAM) United States $0.978B 0.00
Arcus Biosciences (RCUS) United States $0.970B 0.00
Heska (HSKA) United States $0.951B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.932B 40.04
Myriad Genetics (MYGN) United States $0.928B 47.88
Athenex (ATNX) United States $0.915B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.840B 0.00
Dynavax Technologies (DVAX) United States $0.826B 0.00
Cara Therapeutics (CARA) United States $0.802B 0.00
Vericel (VCEL) United States $0.775B 143.25
Intrexon (PGEN) United States $0.768B 0.00
Cellectis S.A (CLLS) France $0.743B 0.00
Pharming Group (PHGUF) Netherlands $0.739B 16.86
Morphic Holding (MORF) United States $0.723B 0.00
Codexis (CDXS) United States $0.718B 0.00
Castle Biosciences (CSTL) United States $0.694B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.681B 0.00
Frequency Therapeutics (FREQ) United States $0.673B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
MiMedx (MDXG) United States $0.637B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.628B 0.00
Kadmon Holdings (KDMN) United States $0.627B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.577B 4.94
Cue Biopharma (CUE) United States $0.566B 0.00
Agenus (AGEN) United States $0.559B 0.00
IBio (IBIO) United States $0.535B 0.00
Athersys (ATHX) United States $0.529B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.527B 0.00
Prothena (PRTA) Ireland $0.509B 0.00
Anika Therapeutics (ANIK) United States $0.506B 22.16
Kala Pharmaceuticals (KALA) United States $0.506B 0.00
AnaptysBio (ANAB) United States $0.503B 0.00
Prometic Life Sciences (LMNL) Canada $0.503B 0.00
MeiraGTx Holdings (MGTX) United States $0.495B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.492B 0.00
Cel-Sci (CVM) United States $0.478B 0.00
AC Immune SA (ACIU) Switzerland $0.474B 0.00
Syros Pharmaceuticals (SYRS) United States $0.474B 0.00
Clovis Oncology (CLVS) United States $0.472B 0.00
UROGEN PHARMA (URGN) United States $0.465B 0.00
Protagonist Therapeutics (PTGX) United States $0.452B 0.00
DBV Technologies S.A (DBVT) France $0.450B 0.00
BioDelivery Sciences (BDSI) United States $0.446B 23.42
Puma Biotechnology (PBYI) United States $0.429B 0.00
Avid Bioservices (CDMO) United States $0.425B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.403B 0.00
Kamada (KMDA) Israel $0.402B 16.70
Merus (MRUS) Netherlands $0.400B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.395B 0.00
Albireo Pharma (ALBO) United States $0.393B 0.00
Scholar Rock Holding (SRRK) United States $0.381B 0.00
PDL BioPharma (PDLI) United States $0.379B 333.00
ANI Pharmaceuticals (ANIP) United States $0.368B 7.16
Geron (GERN) United States $0.360B 0.00
MannKind (MNKD) United States $0.347B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.341B 0.00
Precision BioSciences (DTIL) United States $0.341B 0.00
CytomX Therapeutics (CTMX) United States $0.338B 0.00
WAVE Life Sciences (WVE) Singapore $0.320B 0.00
ChromaDex (CDXC) United States $0.317B 0.00
Trevena (TRVN) United States $0.315B 0.00
Seres Therapeutics (MCRB) United States $0.312B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.310B 0.00
ADMA Biologics Inc (ADMA) United States $0.292B 0.00
OSMOTICA PHARM (OSMT) United States $0.292B 0.00
Affimed (AFMD) Germany $0.290B 0.00
Menlo Therapeutics (MNLO) United States $0.288B 0.00
Pluristem Therapeutics (PSTI) Israel $0.281B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.278B 0.00
Starpharma Holdings (SPHRY) Australia $0.270B 0.00
Cellular Biomedicine (CBMG) United States $0.269B 0.00
Arbutus Biopharma (ABUS) United States $0.264B 0.00
Northwest Biotherapeutics (NWBO) United States $0.264B 0.00
Spero Therapeutics (SPRO) United States $0.257B 0.00
NextCure (NXTC) United States $0.254B 0.00
Pfenex (PFNX) United States $0.252B 0.00
Celldex Therapeutics (CLDX) United States $0.250B 0.00
Dyadic (DYAI) United States $0.249B 0.00
Abeona Therapeutics (ABEO) United States $0.247B 0.00
Fortress Biotech (FBIO) United States $0.239B 0.00
Aduro Biotech (ADRO) United States $0.236B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.235B 0.00
Selecta Biosciences (SELB) United States $0.231B 0.00
Verastem (VSTM) United States $0.231B 0.00
Five Prime Therapeutics (FPRX) United States $0.222B 0.00
HOOKIPA Pharma (HOOK) United States $0.221B 0.00
IVERIC Bio (ISEE) United States $0.220B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.204B 9.50
Exicure (XCUR) United States $0.201B 0.00
Sutro Biopharma (STRO) United States $0.196B 0.00
Strongbridge Biopharma (SBBP) United States $0.194B 0.00
GENFIT S.A (GNFT) France $0.192B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.190B 0.00
XOMA (XOMA) United States $0.190B 0.00
Theratechnologies (THTX) Canada $0.181B 0.00
Aptinyx (APTX) United States $0.180B 0.00
POXEL SA FRANCE (PXXLF) France $0.177B 0.00
Aytu Bioscience (AYTU) United States $0.175B 0.00
Liquidia Technologies (LQDA) United States $0.165B 0.00
Cerecor (CERC) United States $0.162B 0.00
VTv Therapeutics (VTVT) United States $0.161B 0.00
Bellus Health (BLU) Canada $0.160B 0.00
Cidara Therapeutics (CDTX) United States $0.148B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.142B 0.00
Eton Pharmaceuticals (ETON) United States $0.141B 0.00
TELA Bio (TELA) United States $0.139B 0.00
Kindred Biosciences (KIN) United States $0.138B 0.00
Applied Genetic Technologies (AGTC) United States $0.138B 0.00
Windtree Therapeutics (WINT) United States $0.136B 0.00
VolitionRX (VNRX) United States $0.136B 0.00
Celyad SA (CYAD) Belgium $0.136B 0.00
Palatin Technologies (PTN) United States $0.135B 3.47
Lineage Cell Therapeutics (LCTX) United States $0.127B 0.00
Oncobiologics (OTLK) United States $0.127B 0.00
Checkpoint Therapeutics (CKPT) United States $0.126B 0.00
Biofrontera AG (BFRA) Germany $0.126B 0.00
Gritstone Oncology (GRTS) United States $0.124B 0.00
PHASEBIO PHARMA (PHAS) United States $0.123B 0.00
Cocrystal Pharma (COCP) United States $0.123B 0.00
Orgenesis (ORGS) United States $0.119B 0.00
SESEN BIO, INC (SESN) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.116B 0.00
Enzo Biochem (ENZ) United States $0.115B 0.00
Lumos Pharma (LUMO) United States $0.114B 0.00
Cyclerion Therapeutics (CYCN) United States $0.114B 0.00
Cardiff Oncology (CRDF) United States $0.110B 0.00
CorMedix Inc (CRMD) United States $0.109B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.109B 0.00
Vaccinex (VCNX) United States $0.107B 0.00
AIT Therapeutics (XAIR) United States $0.106B 0.00
AquaBounty Technologies (AQB) United States $0.105B 0.00
ARAVIVE, INC (ARAV) United States $0.096B 0.00
Organovo Holdings (ONVO) United States $0.092B 0.00
Antibe Therapeutics (ATBPF) Canada $0.090B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.088B 0.00
DiaMedica Therapeutics (DMAC) United States $0.086B 0.00
Unum Therapeutics (UMRX) United States $0.085B 0.00
Emmaus Life Sciences (EMMA) United States $0.082B 0.00
Adocia (ADOCY) France $0.080B 0.00
Clearside Biomedical (CLSD) United States $0.079B 0.00
Proteostasis Therapeutics (PTI) United States $0.078B 0.00
Ecology Coatings (ABVC) United States $0.076B 0.00
Stealth BioTherapeutics (MITO) United States $0.074B 0.00
Synlogic (SYBX) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.071B 0.00
Bionano Genomics (BNGO) United States $0.066B 0.00
AnPac Bio-Medical Science (ANPC) China $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.066B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Soligenix (SNGX) United States $0.063B 0.00
Signal Genetics (MGEN) United States $0.062B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.061B 0.00
Edesa Biotech (EDSA) Canada $0.061B 0.00
Happiness Biotech Group (HAPP) China $0.061B 0.00
IMMURON (IMRN) Australia $0.055B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.052B 0.00
CollPlant Holdings (CLGN) Israel $0.051B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.051B 0.00
Prima BioMed (IMMP) Australia $0.050B 0.00
Apricus Biosciences (SEEL) United States $0.049B 0.00
Curis (CRIS) United States $0.044B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Spherix (AIKI) United States $0.038B 0.00
ATyr Pharma (LIFE) United States $0.036B 0.00
Celsion (CLSN) United States $0.036B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Cesca Therapeutics (THMO) United States $0.035B 0.00
Genetic Technologies (GENE) Australia $0.035B 0.00
OvaScience (MLND) United States $0.034B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.033B 0.00
Pulmatrix (PULM) United States $0.033B 0.00
Chanticleer Holdings (SONN) United States $0.033B 0.00
Forte Biosciences (FBRX) United States $0.032B 0.00
Acorda Therapeutics (ACOR) United States $0.031B 0.00
Evogene (EVGN) Israel $0.029B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
Cleveland BioLabs (CBLI) United States $0.028B 0.00
Novogen (KZIA) Australia $0.028B 0.00
Aptevo Therapeutics (APVO) United States $0.026B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.023B 0.00
BioPharmX (TMBR) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Prana Biotechnology (ATHE) Australia $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
BioCardia (BCDA) United States $0.017B 0.00
Neuralstem (SNCA) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00